| # | Drug | Count |
|---|---|---|
| 0 | HUMAN IMMUNOGLOBULIN G | 500 |
| 1 | ACETAMINOPHEN | 485 |
| 2 | INFLIXIMAB | 441 |
| 3 | DIPHENHYDRAMINE HYDROCHLORIDE | 440 |
| 4 | ACETAMINOPHEN 500MG | 383 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 383 |
| 6 | PAIN RELIEVER | 383 |
| 7 | EPINEPHRINE | 279 |
| 8 | ADRENALINUM | 266 |
| 9 | DIPHENHYDRAMINE | 264 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COPPER CU 64 DOTATATE | 4 | 0.0741 |
| 1 | HUMAN IMMUNOGLOBULIN G | 500 | 0.0239 |
| 2 | BOTULISM ANTITOXIN HEPTAVALENT | 3 | 0.0233 |
| 3 | CANGRELOR | 8 | 0.0198 |
| 4 | CEFTAZIDIME, AVIBACTAM | 3 | 0.0178 |
| 5 | AMLODIPINE AND VALSARTAN | 3 | 0.0152 |
| 6 | IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) | 60 | 0.0130 |
| 7 | INFLIXIMAB-AXXQ | 15 | 0.0129 |
| 8 | IMMUNE GLOBULIN INFUSION (HUMAN) | 106 | 0.0122 |
| 9 | DINUTUXIMAB | 10 | 0.0116 |
| # | Drug class | Count |
|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 626 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 568 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 532 |
| 3 | Corticosteroid [EPC] | 447 |
| 4 | Osmotic Laxative [EPC] | 337 |
| 5 | Catecholamine [EPC] | 291 |
| 6 | alpha-Adrenergic Agonist [EPC] | 284 |
| 7 | beta-Adrenergic Agonist [EPC] | 284 |
| 8 | Amide Local Anesthetic [EPC] | 247 |
| 9 | Antiarrhythmic [EPC] | 245 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 626 | 0.0297 |
| 1 | Oxaborole Antifungal [EPC] | 1 | 0.0143 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 11 | 0.0101 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 21 | 0.0101 |
| 4 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 5 | Provitamin D2 Compound [EPC] | 206 | 0.0069 |
| 6 | Human alpha-1 Proteinase Inhibitor [EPC] | 29 | 0.0068 |
| 7 | Human Antihemophilic Factor [EPC] | 1 | 0.0065 |
| 8 | Lipid Emulsion [EPC] | 16 | 0.0061 |
| 9 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 17 | 0.0050 |